• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

Three Treatment Options To Consider

May 9, 2025

Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

May 9, 2025

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Saturday, May 10
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

    May 9, 2025

    OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

    May 9, 2025

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Health»Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Health

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

October 11, 2023No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Share
Facebook Twitter LinkedIn Pinterest Email

Topline

More employers could cover popular weight loss and diabetes drugs like Ozempic and Wegovy in 2024, allowing workers to avoid steep out-of-pocket costs, a new survey found—though the drugs’ high costs have caused other workplaces to either stop coverage altogether or up monthly co-pays.

Picture of Wegovy injectable prescription pens for weight.

UCG/Universal Images Group via Getty Images

Key Facts

Around 43% of the 500 employers who participated in a new survey by healthcare advocacy service Accolade and research firm Savanta said they plan on covering GLP-1 receptor agonist medications in 2024, almost double the number that covers them in 2023 (25%).

Ozempic, Wegovy and Mounjaro are part of a class of drugs called GLP-1 receptor agonists that can manage weight loss and type 2 diabetes by interacting with the hunger part of the brain to suppress the appetite and lowering blood sugar and A1C.

About 48% of employers said a lack of trusted information was the biggest obstacle holding them back from covering the drugs for their staff, and 38% cited costs of the medications as a potential problem.

Almost all of the employers who already cover GLP-1 receptor agonists said they’d continue covering them in the future, with one third reporting a “strong financial impact” from adding them and more than two thirds reporting an increase in enrollment after the drugs were added.

Most HR professionals surveyed agree that covering these drugs will help employees’ health in the long run and make employees feel like they have a better insurance package.

However, the costs of these drugs without insurance coverage can be steep, with some costing over $1,000 for a 28-day supply.

Big Number

$77 billion. That’s how large Morgan Stanley estimates the weight loss medication market to be by 2030.

Crucial Quote

“For the 43% planning to offer coverage next year, we recommend a physician-led approach that guides who should be prescribed GLP-1 medications and how to make them part of a holistic health management plan,” James Wantuck, Accolade’s associate chief medical officer, said in a statement part of the survey.

Key Background

Popular weight loss and diabetes medications are expensive without insurance coverage. Eli Lilly’s Mounjaro (which is still seeking FDA approval for weight loss) costs $1,023 per fill, Novo Nordisk’s Wegovy is $1,349.02 per package and Saxenda is also $1,349.02 per fill. Ozempic—though only approved for use in diabetes and used off-label for weight loss—is $935.77 per package. Although pharmaceutical companies offer savings cards for most of these drugs, some people might still have to pay hundreds of dollars out of pocket. Wegovy’s savings card only covers up to $225 per each 28-day supply for 12 fills. The fact that these GLP-1 drugs have rapidly gained popularity has also played a part in their costs. Their popularity has caused multiple shortages as manufacturers couldn’t keep up with demand. Their high demand is due to their decent weight loss results: Mounjaro helps patients lose around 22.5% of body fat, semaglutide (generic name for Wegovy and Ozempic) has been found to cause a 15% reduction in body fat and Saxenda causes a 5% drop.

Contra

Some companies have stopped covering GLP-1 receptor agonists and other anti-obesity drugs due to their high costs. Ascension, a nonprofit healthcare system, stopped coverage in July, forcing employees to pay out of pocket. The University of Texas system stopped coverage in September, citing the cost for the drugs almost tripling over 18 months from $1.5 million to $5 million a month. In its newsletter, the company said continuing coverage was “unsustainable due to the current rate of prescription drug expenditures.” Other large employers like the University of Michigan have opted to increase their monthly copays: The university spent almost $9 million on Wegovy and Saxenda between July 2022 and June 2023, so it’s bumping the copay up from $20 to $45 a month, Bloomberg Law reports. Angela Fitch, president of the Obesity Medicine Association, told Healthline another barrier holding companies back from covering GLP-1 receptor agonists is the fact people have to continuously take them for a long period of time. “When you take into account how long patients are taking them and the number of patients eligible, the cost adds up,” she said.

Further Reading

Wegovy Shortage: Drug Maker Limits Distribution—Here’s When Supplies Should Improve (Forbes)

What To Know About Ozempic: The Diabetes Drug Becomes A Viral Weight Loss Hit (Elon Musk Boasts Using It) Creating A Shortage (Forbes)

Diabetes Drug Mounjaro Expected To Be Approved For Weight Loss Soon: What To Know And How It Compares To Similar Drugs (Forbes)

Insurance Providers Are Halting Coverage of Ozempic and Other GLP-1 Drugs (Healthline)

See also  Alzheimer’s Breakthrough? Researchers Find New Omega-3 Acid That Could Reduce Vision Loss In Patients
costs Cover drugs Employers loss Means Wegovy Weight YearHeres
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Trump Closes Tariff Loophole That Let China Flood America With Knockoff Goods, Drugs

May 2, 2025

What the US Exit From the Information Technology Agreement Means for America and the World

April 14, 2025

Big Pharma Tax Loophole Costs Americans Over $1 Billion Per Year, According To Recent Study

March 19, 2025

China in Pakistan’s Power Sector: The Hidden Costs Behind Pakistan’s Energy Overcapacity

January 21, 2025
Add A Comment

Leave A Reply Cancel Reply

Top Posts

Google Admits Staging Gemini AI Demo Video

December 9, 2023

Legal experts identify the significance of what is missing from Jack Smith’s newest indictment against Donald Trump

August 2, 2023

Resistance to cancer drugs: A new genetic explanation

July 19, 2023

Yokohama FC vs Gamba Osaka Prediction and Betting Tips

June 29, 2023
Don't Miss

Three Treatment Options To Consider

Lifestyle May 9, 2025

The most common cause of hair loss in men is male androgenetic alopecia (MAA), otherwise…

Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

May 9, 2025

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,112)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,629)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

Lung Health ‘Crisis’ Costing U.K. $860 Million Per Year

September 30, 2023

President Biden Takes Historic Steps To Combat Sexual Violence In Conflict Zones

June 21, 2023

Suspect in Los Angeles Dismembered Torso Case Is Hollywood Scion, Whose Wife and In-Laws Remain Missing

November 11, 2023
Popular Posts

Three Treatment Options To Consider

May 9, 2025

Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

May 9, 2025

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.